A detailed history of Core Alternative Capital transactions in Embecta Corp. stock. As of the latest transaction made, Core Alternative Capital holds 2 shares of EMBC stock, worth $29. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$29
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$12.35 - $19.33 $185 - $289
-15 Reduced 88.24%
2 $0
Q4 2023

Feb 14, 2024

SELL
$12.87 - $19.09 $12 - $19
-1 Reduced 5.56%
17 $0
Q2 2023

Jul 27, 2023

BUY
$21.6 - $30.69 $64 - $92
3 Added 20.0%
18 $0
Q1 2023

Apr 18, 2023

BUY
$23.07 - $32.77 $23 - $32
1 Added 7.14%
15 $0
Q4 2022

Jan 31, 2023

SELL
$25.29 - $35.48 $25 - $35
-1 Reduced 6.67%
14 $0
Q2 2022

Aug 01, 2022

BUY
$24.78 - $33.36 $371 - $500
15 New
15 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $850M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Core Alternative Capital Portfolio

Follow Core Alternative Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.